- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Umbilical hernia.
Displaying page 1 of 1.
EudraCT Number: 2014-002802-19 | Sponsor Protocol Number: NMBDKHernia2014 | Start Date*: 2014-09-19 | |||||||||||
Sponsor Name:Department of Anaesthesiology | |||||||||||||
Full Title: Optimizing surgical conditions during laparoscopic umbilical, incisional –and linea alba herniotomy with deep neuromuscular blockade (The hernia study) | |||||||||||||
Medical condition: The purpose of this study is to investigate surgical work space and surgical conditions in patients scheduled for laparoscopic umbilical, -linea alba and incisional herniotomy. The patients will ac... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003789-25 | Sponsor Protocol Number: mela1 | Start Date*: 2015-02-26 | |||||||||||
Sponsor Name:Department of surgery, Herlev Hospital | |||||||||||||
Full Title: The anxiolytic effects of melatonin: A randomized, placebo-controlled, double-blinded clinical study. | |||||||||||||
Medical condition: We intend to investigate the anxiolytic effects of melatonin in relation to surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003502-28 | Sponsor Protocol Number: AP-325.04 | Start Date*: 2020-02-14 | |||||||||||
Sponsor Name:Algiax Pharmaceuticals GmbH | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of AP-325 in Subjects with Peripheral Post-surgical Neuropathic Pain | |||||||||||||
Medical condition: Peripheral post-surgical neuropathic pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003181-12 | Sponsor Protocol Number: HOTPOT1 | Start Date*: 2016-10-07 |
Sponsor Name:Royal College of Surgeons in Ireland | ||
Full Title: Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? | ||
Medical condition: Persistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition occurring in 7/1000 births and can result in significant cardiovascular instability in the newborn. It occur... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002051-42 | Sponsor Protocol Number: R119861 | Start Date*: 2019-10-25 | |||||||||||
Sponsor Name:University of Manchester | |||||||||||||
Full Title: A phase I-II, study of autologous CD34+ haematopoietic stem cells transduced ex vivo with CD11b lentiviral vector encoding for human SGSH in patients with mucopolysaccharidosis type IIIA (MPS IIIA,... | |||||||||||||
Medical condition: MPS IIIA, mucopolysaccharidosis type IIIA | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
